SCHEMBL6654078

SCHEMBL6654078

COC(=O)C1=C(O)CCc2ccccc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.52
KDM4E B2RXH2 5/20 0.52
HPGD P15428 4/20 0.52
L3MBTL1 Q9Y468 3/20 0.52
FGFR1 P11362 1/20 0.43
SRC P12931 1/20 0.43
FGFR2 P21802 1/20 0.43
FGFR4 P22455 1/20 0.43
FGFR3 P22607 1/20 0.43
RAB9A P51151 6/20 0.42
NPC1 O15118 4/20 0.42
SMN1; SMN2 Q16637 5/20 0.41
CES1 P23141 1/20 0.41
MAPT P10636 7/20 0.41
MITF O75030 1/20 0.41
TSHR P16473 2/20 0.41
LMNA P02545 2/20 0.41
KMT2A Q03164 1/20 0.40
TDP1 Q9NUW8 2/20 0.40
NOTUM Q6P988 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11099181 0.83 ALDH1A1 (0.52) ALDH1A1KDM4EHPGDL3MBTL1FGFR1
SCHEMBL6673635 0.83 HPGD (0.56) ALDH1A1KDM4EHPGDL3MBTL1RAB9A
SCHEMBL6526952 0.82 ALDH1A1 (0.51) ALDH1A1KDM4EHPGDL3MBTL1FGFR1
SCHEMBL6676615 0.79 SRD5A2 (0.51) ALDH1A1KDM4EHPGDL3MBTL1RAB9A
SCHEMBL588713 0.78 RAB9A (0.58) ALDH1A1KDM4EHPGDL3MBTL1RAB9A
SCHEMBL6648373 0.78 L3MBTL1 (0.42) ALDH1A1KDM4EHPGDL3MBTL1SMN1; SMN2
SCHEMBL588072 0.78 MAPK14 (0.43) ALDH1A1KDM4EHPGDL3MBTL1RAB9A
SCHEMBL587938 0.78 SRD5A1 (0.48) KDM4EL3MBTL1RAB9AMAPTTDP1
SCHEMBL8028626 0.78 FGFR1 (0.44) ALDH1A1KDM4EHPGDL3MBTL1FGFR1
SCHEMBL27617877 0.77 ALDH1A1 (0.56) ALDH1A1KDM4EHPGDL3MBTL1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6762188-B1 INHIBITING THYMIDYLATE SYNTHASE; COLON, BREAST OR LUNG CARCINOMA SMITHKLINE BEECHAM CORPORATION 2004-07-13 US disclosed
EP-1199307-B1 Pharmaceutically active benzoquinazoline compounds WELLCOME FOUND (GB) 2004-02-25 EP disclosed
EP-1199307-A1 Pharmaceutically active benzoquinazoline compounds THE WELLCOME FOUNDATION LIMITED (GB) 2002-04-24 EP disclosed
US-6306865-B1 SYNTHASE INHIBITORS AND ANTITUMOR AGENTS GLAXO WELLCOME INC. 2001-10-23 US disclosed
US-6090941-A Pharmaceutically active benzoquinazoline compounds GLAXO WELLCOME INC. (US) 2000-07-18 US disclosed
US-5663337-A ENZYME, ANTITUMOR GLAXO WELLCOME INC. (US) 1997-09-02 US disclosed
US-5661155-A THYMIDYLATE SYNTHASE INHIBITOR; ADMINISTERING TO THE MAMMAL SUFFERING FROM LEUKEMIA OR TUMOR 2-(5-(((1,2-DIHYDRO-3-METHYL-1-OXOBENZO(F)QUINAZOLINE-9-YL) METHYL)AMINO)-1-OXO-2-ISOINDOLINYL)GLUTARIC ACID OR SALTS GLAXO WELLCOME INC. (US) 1997-08-26 US disclosed
US-5405851-A Administering benzoquinazoline thymidylate synthase inhibitors BURROUGHS WELLCOME CO. (US) 1995-04-11 US disclosed
EP-0535034-A1 PHARMACEUTICALLY ACTIVE BENZOQUINAZOLINE COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1993-04-07 EP disclosed
WO-1991019700-A1 PHARMACEUTICALLY ACTIVE BENZOQUINAZOLINE COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1991-12-26 WO disclosed